OXYCODONE/NALOXONE COMBINATION PRODUCTS
Clinical Indication
Pain not associated with opioid-induced bowel dysfunction
Comments
As agreed at FWP September 22
Date of classification
October 2022
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.